Concepedia

Publication | Open Access

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

99

Citations

47

References

2020

Year

Abstract

SUMO inhibitor-based therapies should be further developed for an aggressive PDAC subtype.

References

YearCitations

Page 1